NASDAQ: BCTXBriacell Therapeutics Corp Stock Ownership - Who owns Briacell Therapeutics?
Insider buying vs selling
Have Briacell Therapeutics Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BCTX insiders and whales buy or sell their stock.
BCTX Shareholders
What type of owners hold Briacell Therapeutics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Marc Lustig | 222.04% | 4,182,935 | $17.44M | Insider |
| Jamieson Bondarenko | 9.02% | 169,856 | $708.30k | Insider |
| Williams V. Williams | 7.94% | 149,636 | $623.98k | Insider |
| Citadel Advisors LLC | 0.59% | 11,055 | $46.10k | Institution |
| Vaughn C. Embropantalony | 0.51% | 9,524 | $39.72k | Insider |
| Gadi Levin | 0.15% | 2,810 | $11.72k | Insider |
| Federation Des Caisses Desjardins Du Quebec | 0.05% | 905 | $3.77k | Institution |
| Martin E. Schmieg | 0.03% | 575 | $2.40k | Insider |
| Morgan Stanley | 0.01% | 114 | $475.38 | Institution |
| Royal Bank Of Canada | 0.01% | 100 | $417.00 | Institution |
BCTX vs Biotech Stocks
Briacell Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.